Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Relmada Therapeutics, Inc. (RLMD)
USD6.43
-0.03 (-0.39%)
US NASDAQ Healthcare Biotechnology
Address
2222 Ponce de Leon Blvd. 33134
Coral Gables, FL, US
Coral Gables, FL, US
CEO
Sergio Traversa
Website
relmada.com
IPO
2014-06-20
CIK 1553643 ISIN US75955J4022
Description
Relmada Therapeutics, Inc. operates as a clinical-stage biotechnology company in the United States. The company focuses on the development of NDV-01, a controlled-release intravesical formulation of gemcitabine and docetaxel, which is in Phase 2 clinical trial for patients with aggressive forms of non-muscle invasive bladder cancer; and Sepranolone, a neurosteroid epimer of allopregnanolone, which is Phase 2b-ready for the potential treatment of prader-willi syndrome, tourette syndrome, excessive tremor, and other diseases related to excessive GABAergic activity. The company has an agreement with Asarina Pharma AB and Trigone. Relmada Therapeutics, Inc. was founded in 2004 and is headquartered in Coral Gables, Florida.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD6.43
-0.03 (-0.39%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
2M
Beta
0.39
Float Shares
60.48M
Free Float %
82.5%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.54% | +0.13% | +1.49% | +101.34% | +93.04% | +55.07% | +1,820.51% | +869.58% | +11.79% | +246.76% | -37.58% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (8 ratings, all time)
Buy
Price Targets & DCF
Current price
6.43
Low
8.00
+24.5%
Consensus
9.00
+40.1%
Median
9.00
+40.1%
High
10.00
+55.6%
DCF (Unlevered)
0.05
-99.2%
DCF (Levered)
0.09
-98.6%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 4 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | 1 |
10.00
+55.6%
|
| Last Year | 3 |
9.00
+40.1%
|
| All Time | 6 |
7.33
+14.1%
|
Quality scores
Altman Z-Score
15.73
Safe zone
Piotroski F-Score
3 / 9
Average
MOAT Score
3 / 10
No MOAT
Composite Rating
C-
Overall Score
1 / 5
Low
DCF Score
2 / 5
Medium
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
2 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%—
-
EPS growth Biotechnology: +29.7%+45.3% ★ Q1'26: +62.1% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%—
-
EBIT margin Biotechnology: +0.0%—
-
ROIC Biotechnology: -16.1%— Q1'26: +0.0% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+30.9% Q1'26: +184.8% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×0.00× Q1'26: 0.00× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 4 Rev. Ana. 3 EPS Ana. |
Dec 2027 5 Rev. Ana. 2 EPS Ana. |
Dec 2028 3 Rev. Ana. 3 EPS Ana. |
Dec 2029 2 Rev. Ana. 1 EPS Ana. |
Dec 2030 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|
| Revenue |
—
|
—
est: 2.46M (-100.0%)
|
10.00M
10.00M – 10.00M
+306.7% YoY
|
32.45M
32.45M – 32.45M
+224.5% YoY
|
19.00M
19.00M – 19.00M
-41.4% YoY
|
88.40M
88.40M – 88.40M
+365.2% YoY
|
144.45M
144.45M – 144.45M
+63.4% YoY
|
| EBITDA |
-83.89M
|
-59.10M
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| EBIT |
-83.89M
|
-59.10M
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| Net Income |
-79.98M
est: -81.54M (+1.9%)
|
-57.39M
est: -41.35M (-38.8%)
|
-29.00M
-32.96M – -25.03M
+29.9% YoY
|
-37.50M
-39.58M – -35.43M
-29.3% YoY
|
-40.86M
-49.35M – -32.37M
-9.0% YoY
|
-26.19M
-26.19M – -26.19M
+35.9% YoY
|
-17.50M
-17.50M – -17.50M
+33.2% YoY
|
| SGA |
37.72M
|
311.9K
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| EPS |
-2.65
est: -2.70 (+2.0%)
|
-1.45
est: -1.05 (-38.4%)
|
-0.76
-0.83 – -0.63
+27.4% YoY
|
-0.95
-1.00 – -0.90
-25.4% YoY
|
-0.98
-1.25 – -0.82
-2.4% YoY
|
-0.66
-0.66 – -0.66
+32.1% YoY
|
-0.44
-0.44 – -0.44
+33.2% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-08 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-07 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-06 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-05 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-04 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-01 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-30 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-29 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-28 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-27 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-24 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-23 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-22 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-21 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-20 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-17 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-16 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-15 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-12.09M
OE per share TTM
-1.31
Owner's Yield
-2.41%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
11,537.0%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
14
Total invested
10.22M
Insider transactions (90d)
0
Beneficial owners (>5%)
42
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | David Kroin | 2.48M | 8.25% | — | 2.48M | — | — | HC, IN | Cayman Islands | 2022-10-21 | ↗ |
| 2 | Deep Track Biotechnology Master Fund, Ltd. | 2.48M | 8.25% | — | 2.48M | — | — | CO | Cayman Islands | 2022-10-21 | ↗ |
| 3 | Deep Track Capital, LP | 2.48M | 8.25% | — | 2.48M | — | — | IA, OO | Cayman Islands | 2022-10-21 | ↗ |
| 4 | Koh, Bong | 2.27M | 8.20% | — | 2.27M | — | 2.27M | IN | United States | 2022-02-14 | ↗ |
| 5 | Shah, Nimish | 2.27M | 8.20% | — | 2.27M | — | 2.27M | IN | United States | 2022-02-14 | ↗ |
| 6 | VHCP Co-Investment Holdings II, LLC | 2.27M | 8.20% | — | 2.27M | — | 2.27M | OO | Delaware | 2022-02-14 | ↗ |
| 7 | VHCP Co-Investment Holdings III, LLC | 2.27M | 8.20% | — | 2.27M | — | 2.27M | OO | Delaware | 2022-02-14 | ↗ |
| 8 | VHCP Management EG, LLC | 2.27M | 8.20% | — | 2.27M | — | 2.27M | OO | Delaware | 2022-02-14 | ↗ |
| 9 | VHCP Management II, LLC | 2.27M | 8.20% | — | 2.27M | — | 2.27M | OO | Delaware | 2022-02-14 | ↗ |
| 10 | VHCP Management III, LLC | 2.27M | 8.20% | — | 2.27M | — | 2.27M | OO | Delaware | 2022-02-14 | ↗ |
| 11 | Venrock Healthcare Capital Partners EG, L.P. | 2.27M | 8.20% | — | 2.27M | — | 2.27M | PN | Delaware | 2022-02-14 | ↗ |
| 12 | Venrock Healthcare Capital Partners II, L.P. | 2.27M | 8.20% | — | 2.27M | — | 2.27M | PN | Delaware | 2022-02-14 | ↗ |
| 13 | Venrock Healthcare Capital Partners III, L.P. | 2.27M | 8.20% | — | 2.27M | — | 2.27M | PN | Delaware | 2022-02-14 | ↗ |
| 14 | Steven A. Cohen | 2.10M | 4.00% | — | 2.10M | — | 2.10M | IN | Delaware | 2022-10-17 | ↗ |
| 15 | Advisors LLC | 2.10M | 7.00% | — | 2.10M | — | 2.10M | IA | Delaware | 2022-09-23 | ↗ |
| 16 | Edelman | 2.10M | 7.00% | — | 2.10M | — | 2.10M | IN | Delaware | 2022-09-23 | ↗ |
| 17 | Sciences Master Fund, Ltd. | 2.10M | 7.00% | — | 2.10M | — | 2.10M | CO | Delaware | 2022-09-23 | ↗ |
| 18 | Point72 Asset Management, L.P. | 2.08M | 4.00% | — | 2.08M | — | 2.08M | PN | Delaware | 2022-10-17 | ↗ |
| 19 | Point72 Capital Advisors, Inc. | 2.08M | 4.00% | — | 2.08M | — | 2.08M | CO | Delaware | 2022-10-17 | ↗ |
| 20 | Peter Kolchinsky | 2.00M | 7.20% | — | 2.00M | — | — | HC, IN | United States of America | 2021-12-20 | ↗ |
| 21 | RA Capital Healthcare Fund, L.P. | 2.00M | 7.20% | — | 2.00M | — | — | PN | United States of America | 2021-12-20 | ↗ |
| 22 | RA Capital Management, L.P. | 2.00M | 7.20% | — | 2.00M | — | — | IA, PN | United States of America | 2021-12-20 | ↗ |
| 23 | Rajeev Shah | 2.00M | 7.20% | — | 2.00M | — | — | HC, IN | United States of America | 2021-12-20 | ↗ |
| 24 | Kevin Kotler | 1.90M | 6.30% | 1.90M | — | 1.90M | — | IN | United States of America | 2022-12-20 | ↗ |
| 25 | BVF Inc. | 1.65M | 5.90% | — | — | — | 1.65M | CO | Delaware | 2021-12-20 | ↗ |
| 26 | BVF Partners L.P. | 1.65M | 5.90% | — | — | — | 1.65M | IA, PN | Delaware | 2021-12-20 | ↗ |
| 27 | Mark N. Lampert | 1.65M | 5.90% | — | — | — | 1.65M | IN | Delaware | 2021-12-20 | ↗ |
| 28 | BVF GP HOLDINGS LLC | 1.52M | 5.50% | — | — | — | 1.52M | OO | Delaware | 2021-12-20 | ↗ |
| 29 | The Vanguard Group - 23-1945930 | 1.52M | 5.04% | — | 34.6K | 1.47M | 45.1K | IA | — | 2023-02-09 | ↗ |
| 30 | RTW Investments, LP | 1.51M | 9.31% | — | 1.51M | — | 1.51M | IA, PN, OO | OR PLACE OF ORGANIZATION | 2021-02-12 | ↗ |
| 31 | (1) BlackRock, Inc. | 1.39M | 5.20% | 1.36M | — | 1.39M | — | HC | Delaware | 2022-02-03 | ↗ |
| 32 | RTW Master Fund, Ltd. | 1.06M | 6.50% | — | 1.06M | — | 1.06M | CO | OR PLACE OF ORGANIZATION | 2021-02-12 | ↗ |
| 33 | BVF I GP LLC | 840.3K | 3.00% | — | — | — | 840.3K | OO | Delaware | 2021-12-20 | ↗ |
| 34 | Biotechnology Value Fund, L.P. | 840.3K | 3.00% | — | — | — | 840.3K | PN | Delaware | 2021-12-20 | ↗ |
| 35 | BVF II GP LLC | 680.9K | 2.50% | — | — | — | 680.9K | OO | Delaware | 2021-12-20 | ↗ |
| 36 | Biotechnology Value Fund II, L.P. | 680.9K | 2.50% | — | — | — | 680.9K | PN | Delaware | 2021-12-20 | ↗ |
| 37 | BVF Partners OS Ltd. | 94.4K | 1.00% | — | — | — | 94.4K | CO | Delaware | 2021-12-20 | ↗ |
| 38 | Biotechnology Value Trading Fund OS LP | 94.4K | 1.00% | — | — | — | 94.4K | PN | Delaware | 2021-12-20 | ↗ |
| 39 | Cubist Systematic Strategies, LLC | 20.7K | 4.00% | — | 20.7K | — | 20.7K | OO | Delaware | 2022-10-17 | ↗ |
| 40 | 2. | 10.00 | 2.90% | — | 862.3K | — | — | HC, PN | Delaware | 2022-10-17 | ↗ |
| 41 | Avoro Capital Advisors LLC | — | 0.00% | — | — | — | — | IA, OO | Delaware | 2022-02-11 | ↗ |
| 42 | Behzad Aghazadeh | — | 0.00% | — | — | — | — | IN | United States | 2022-02-11 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
14
-70 vs prev Q
New positions
3
Closed positions
68
Increased
5
Reduced
2
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | JANUS HENDERSON GROUP PLC | 7.27M +7.3M (+100.0%) | 35.04M +35.0M (+100.0%) | 21.90% +21.903 pp | 0.02% +0.016 pp | USD4.83 +0.0% | 1 qtrs NEW |
| 2 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 4.27M +4.3M (+100.0%) | 20.62M +20.6M (+100.0%) | 12.86% +12.865 pp | 0.03% +0.031 pp | USD4.83 +0.0% | 1 qtrs NEW |
| 3 | MARSHALL WACE, LLP | 3.19M +2.9M (+1,072.4%) | 15.41M +14.9M (+2,717.4%) | 9.61% +8.790 pp | 0.01% +0.014 pp | USD4.52 +6.9% | 3 qtrs — |
| 4 | IKARIAN CAPITAL, LLC | 3.07M +1.2M (+66.5%) | 14.82M +11.1M (+300.1%) | 9.24% +3.692 pp | 1.16% +0.783 pp | USD3.12 +54.8% | 13 qtrs — |
| 5 | ORBIMED ADVISORS LLC | 2.61M +2.6M (+100.0%) | 12.61M +12.6M (+100.0%) | 7.87% +7.865 pp | 0.26% +0.258 pp | USD4.83 +0.0% | 1 qtrs NEW |
| 6 | AMERIPRISE FINANCIAL INC | 1.92M +1.9M (+100.0%) | 9.27M +9.3M (+100.0%) | 5.78% +5.785 pp | 0.00% +0.002 pp | USD4.83 +0.0% | 1 qtrs NEW |
| 7 | DRIEHAUS CAPITAL MANAGEMENT LLC | 1.88M +1.1M (+154.1%) | 9.08M +7.6M (+510.5%) | 5.66% +3.435 pp | 0.06% +0.051 pp | USD3.17 +52.4% | 3 qtrs — |
| 8 | MILLENNIUM MANAGEMENT LLC | 1.67M +1.7M (+100.0%) | 8.08M +8.1M (+100.0%) | 5.04% +5.041 pp | 0.00% +0.003 pp | USD4.83 +0.0% | 1 qtrs NEW |
| 9 | BRAIDWELL LP | 1.58M +1.6M (+100.0%) | 7.64M +7.6M (+100.0%) | 4.77% +4.767 pp | 0.24% +0.244 pp | USD4.83 +0.0% | 1 qtrs NEW |
| 10 | BLACKROCK, INC. | 1.27M +759.5K (+149.5%) | 6.12M +5.1M (+499.6%) | 3.82% +2.288 pp | 0.00% +0.000 pp | USD3.22 +50.0% | 6 qtrs — |
| 11 | VANGUARD GROUP INC | 1.20M +784.7K (+187.5%) | 5.81M +5.0M (+590.8%) | 3.63% +2.364 pp | 0.00% +0.000 pp | USD5.17 -6.6% | 25 qtrs — |
| 12 | OPALEYE MANAGEMENT INC. | 935.0K +935.0K (+100.0%) | 4.52M +4.5M (+100.0%) | 2.82% +2.817 pp | 0.60% +0.596 pp | USD4.83 +0.0% | 1 qtrs NEW |
| 13 | GEODE CAPITAL MANAGEMENT, LLC | 854.9K +558.7K (+188.6%) | 4.13M +3.5M (+593.7%) | 2.58% +1.683 pp | 0.00% +0.000 pp | USD4.88 -1.0% | 25 qtrs — |
| 14 | BOOTHBAY FUND MANAGEMENT, LLC | 835.3K +142.1K (+20.5%) | 4.03M +2.6M (+189.5%) | 2.52% +0.428 pp | 0.06% +0.040 pp | USD2.49 +94.0% | 2 qtrs — |
| 15 | CI PRIVATE WEALTH, LLC | 719.6K +512.9K (+248.2%) | 3.44M +3.0M (+756.6%) | 2.17% +1.545 pp | 0.00% +0.004 pp | USD3.62 +33.4% | 3 qtrs — |
| 16 | TWO SIGMA INVESTMENTS, LP | 572.8K +399.2K (+229.9%) | 2.77M +2.4M (+692.9%) | 1.73% +1.203 pp | 0.00% +0.003 pp | USD3.83 +26.1% | 16 qtrs — |
| 17 | BALYASNY ASSET MANAGEMENT L.P. | 547.9K +547.9K (+100.0%) | 2.65M +2.6M (+100.0%) | 1.65% +1.651 pp | 0.00% +0.003 pp | USD4.83 +0.0% | 1 qtrs NEW |
| 18 | ACADIAN ASSET MANAGEMENT LLC | 526.7K -55.8K (-9.6%) | 2.54M +1.4M (+117.2%) | 1.59% -0.168 pp | 0.00% +0.002 pp | USD0.84 +475.0% | 13 qtrs — |
| 19 | DIADEMA PARTNERS LP | 389.4K +389.4K (+100.0%) | 1.88M +1.9M (+100.0%) | 1.17% +1.173 pp | 0.32% +0.324 pp | USD4.83 +0.0% | 1 qtrs NEW |
| 20 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 385.9K +247.5K (+178.8%) | 1.86M +1.6M (+570.0%) | 1.16% +0.746 pp | 0.00% +0.000 pp | USD3.58 +34.9% | 3 qtrs — |
| 21 | STATE STREET CORP | 320.8K +219.0K (+215.1%) | 1.55M +1.3M (+657.1%) | 0.97% +0.660 pp | 0.00% +0.000 pp | USD5.21 -7.3% | 24 qtrs — |
| 22 | ADVISORSHARES INVESTMENTS LLC | 319.5K -84.0K (-20.8%) | 1.54M +732.2K (+90.3%) | 0.96% -0.253 pp | 0.26% +0.125 pp | USD0.97 +397.9% | 14 qtrs — |
| 23 | JANE STREET GROUP, LLC | 271.1K +185.4K (+216.5%) | 1.31M +1.1M (+660.5%) | 0.82% +0.559 pp | 0.00% +0.000 pp | USD3.49 +38.4% | 3 qtrs — |
| 24 | PARSONS CAPITAL MANAGEMENT INC/RI | 263.0K +99.7K (+61.0%) | 1.27M +942.0K (+286.9%) | 0.79% +0.300 pp | 0.07% +0.051 pp | USD4.27 +13.1% | 25 qtrs — |
| 25 | PERSISTENT ASSET PARTNERS LTD | 231.1K +231.1K (+100.0%) | 1.12M +1.1M (+100.0%) | 0.70% +0.696 pp | 0.50% +0.501 pp | USD4.83 +0.0% | 1 qtrs NEW |
| 26 | DEUTSCHE BANK AG\ | 224.8K +— (+0.0%) | 1.09M +634.1K (+140.3%) | 0.68% +0.000 pp | 0.00% +0.000 pp | USD1.12 +331.3% | 23 qtrs — |
| 27 | POINT72 ASSET MANAGEMENT, L.P. | 187.4K +187.4K (+100.0%) | 905.0K +905.0K (+100.0%) | 0.56% +0.565 pp | 0.00% +0.001 pp | USD4.83 +0.0% | 1 qtrs NEW |
| 28 | RENAISSANCE TECHNOLOGIES LLC | 185.0K +15.3K (+9.0%) | 893.6K +552.5K (+162.0%) | 0.56% +0.046 pp | 0.00% +0.001 pp | USD1.18 +309.3% | 13 qtrs — |
| 29 | NORTHERN TRUST CORP | 165.5K +106.4K (+180.3%) | 799.1K +680.5K (+573.6%) | 0.50% +0.321 pp | 0.00% +0.000 pp | USD4.59 +5.2% | 25 qtrs — |
| 30 | EAM INVESTORS, LLC | 162.6K +162.6K (+100.0%) | 785.1K +785.1K (+100.0%) | 0.49% +0.490 pp | 0.09% +0.087 pp | USD4.83 +0.0% | 1 qtrs NEW |
| 31 | TWO SIGMA ADVISERS, LP | 162.2K +123.4K (+318.0%) | 783.4K +705.4K (+904.5%) | 0.49% +0.372 pp | 0.00% +0.001 pp | USD3.98 +21.4% | 14 qtrs — |
| 32 | QUBE RESEARCH & TECHNOLOGIES LTD | 155.5K +155.5K (+100.0%) | 751.2K +751.2K (+100.0%) | 0.47% +0.469 pp | 0.00% +0.001 pp | USD4.83 +0.0% | 1 qtrs NEW |
| 33 | — | 154.1K +154.1K (+100.0%) | 744.3K +744.3K (+100.0%) | 0.46% +0.464 pp | 0.57% +0.566 pp | USD4.83 +0.0% | 1 qtrs NEW |
| 34 | GOLDMAN SACHS GROUP INC | 145.0K +145.0K (+100.0%) | 700.4K +700.4K (+100.0%) | 0.44% +0.437 pp | 0.00% +0.000 pp | USD4.83 +0.0% | 1 qtrs NEW |
| 35 | RBF CAPITAL, LLC | 140.0K -23.3K (-14.2%) | 676.2K +348.0K (+106.1%) | 0.42% -0.070 pp | 0.03% +0.015 pp | USD0.61 +691.8% | 11 qtrs — |
| 36 | SQUAREPOINT OPS LLC | 138.2K +138.2K (+100.0%) | 667.7K +667.7K (+100.0%) | 0.42% +0.417 pp | 0.00% +0.001 pp | USD4.83 +0.0% | 1 qtrs NEW |
| 37 | MGO ONE SEVEN LLC | 100.0K +— (+0.0%) | 483.0K +282.0K (+140.3%) | 0.30% +0.000 pp | 0.01% +0.005 pp | USD0.62 +679.0% | 11 qtrs — |
| 38 | SEI INVESTMENTS CO | 99.0K +99.0K (+100.0%) | 478.0K +478.0K (+100.0%) | 0.30% +0.298 pp | 0.00% +0.001 pp | USD4.83 +0.0% | 1 qtrs NEW |
| 39 | CAPTION MANAGEMENT, LLC | 73.6K +73.6K (+100.0%) | 355.5K +355.5K (+100.0%) | 0.22% +0.222 pp | 0.00% +0.002 pp | USD4.83 +0.0% | 1 qtrs NEW |
| 40 | EXODUSPOINT CAPITAL MANAGEMENT, LP | 68.9K +68.9K (+100.0%) | 332.7K +332.7K (+100.0%) | 0.21% +0.208 pp | 0.00% +0.003 pp | USD4.83 +0.0% | 1 qtrs NEW |
| 41 | OMERS ADMINISTRATION CORP | 65.9K +65.9K (+100.0%) | 318.3K +318.3K (+100.0%) | 0.20% +0.199 pp | 0.00% +0.002 pp | USD4.83 +0.0% | 1 qtrs NEW |
| 42 | MORGAN STANLEY | 62.4K +61.3K (+5,901.6%) | 301.2K +299.1K (+14,324.6%) | 0.19% +0.185 pp | 0.00% +0.000 pp | USD4.80 +0.6% | 25 qtrs — |
| 43 | BARCLAYS PLC | 60.0K -86.0K (-58.9%) | 289.8K -183.2K (-38.7%) | 0.18% -0.259 pp | 0.00% 0.000 pp | USD2.01 +140.3% | 16 qtrs — |
| 44 | LMR PARTNERS LLP | 55.6K +— (+0.0%) | 268.5K +156.8K (+140.3%) | 0.17% +0.000 pp | 0.00% +0.000 pp | USD0.61 +691.8% | 3 qtrs — |
| 45 | QUADRATURE CAPITAL LTD | 53.4K +53.4K (+100.0%) | 258.1K +258.1K (+100.0%) | 0.16% +0.161 pp | 0.00% +0.003 pp | USD4.83 +0.0% | 1 qtrs NEW |
| 46 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 53.1K +53.1K (+100.0%) | 256.4K +256.4K (+100.0%) | 0.16% +0.160 pp | 0.00% +0.000 pp | USD4.83 +0.0% | 1 qtrs NEW |
| 47 | APRICUS WEALTH, LLC | 47.5K +— (+0.0%) | 229.2K +133.8K (+140.3%) | 0.14% +0.000 pp | 0.12% +0.066 pp | USD6.39 -24.4% | 17 qtrs — |
| 48 | PALE FIRE CAPITAL SE | 44.6K +44.6K (+100.0%) | 215.2K +215.2K (+100.0%) | 0.13% +0.134 pp | 0.01% +0.014 pp | USD4.83 +0.0% | 1 qtrs NEW |
| 49 | UBS GROUP AG | 41.5K -18.3K (-30.6%) | 200.3K +80.1K (+66.7%) | 0.12% -0.055 pp | 0.00% +0.000 pp | USD0.72 +570.8% | 25 qtrs — |
| 50 | XTX TOPCO LTD | 41.3K +41.3K (+100.0%) | 199.4K +199.4K (+100.0%) | 0.12% +0.124 pp | 0.01% +0.005 pp | USD4.83 +0.0% | 3 qtrs — |
| 51 | CARTESIAN GROWTH CORP | 32.0K +— (+0.0%) | 154.4K +90.2K (+140.3%) | 0.10% +0.000 pp | 0.00% +0.002 pp | USD1.03 +368.9% | 9 qtrs — |
| 52 | ADAR1 CAPITAL MANAGEMENT, LLC | 30.9K +30.9K (+100.0%) | 149.1K +149.1K (+100.0%) | 0.09% +0.093 pp | 0.01% +0.011 pp | USD4.83 +0.0% | 3 qtrs — |
| 53 | MANGROVE PARTNERS | 27.4K +27.4K (+100.0%) | 132.2K +132.2K (+100.0%) | 0.08% +0.083 pp | 0.01% +0.011 pp | USD4.83 +0.0% | 1 qtrs NEW |
| 54 | HUDSON BAY CAPITAL MANAGEMENT LP | 26.2K +26.2K (+100.0%) | 126.8K +126.8K (+100.0%) | 0.08% +0.079 pp | 0.00% +0.000 pp | USD4.83 +0.0% | 1 qtrs NEW |
| 55 | GRAHAM CAPITAL MANAGEMENT, L.P. | 25.6K +25.6K (+100.0%) | 123.7K +123.7K (+100.0%) | 0.08% +0.077 pp | 0.00% +0.003 pp | USD4.83 +0.0% | 1 qtrs NEW |
| 56 | BANK OF AMERICA CORP /DE/ | 25.3K +25.1K (+9,535.0%) | 122.4K +121.9K (+23,080.5%) | 0.08% +0.076 pp | 0.00% +0.000 pp | USD4.79 +0.8% | 24 qtrs — |
| 57 | ROBERTSON STEPHENS WEALTH MANAGEMENT, LLC | 25.0K +— (+0.0%) | 120.8K +70.5K (+140.3%) | 0.08% +0.000 pp | 0.00% +0.002 pp | USD0.52 +828.8% | 5 qtrs — |
| 58 | CITIGROUP INC | 22.5K +22.5K (+1,126,600.0%) | 108.8K +108.8K (+2,720,875.0%) | 0.07% +0.068 pp | 0.00% +0.000 pp | USD4.83 +0.0% | 25 qtrs — |
| 59 | JEFFERIES FINANCIAL GROUP INC. | 21.7K +21.7K (+100.0%) | 104.6K +104.6K (+100.0%) | 0.07% +0.065 pp | 0.00% +0.001 pp | USD4.83 +0.0% | 1 qtrs NEW |
| 60 | PANDORA WEALTH, INC. | 20.0K +— (+0.0%) | 96.6K +56.4K (+140.3%) | 0.06% +0.000 pp | 0.06% +0.034 pp | USD0.27 +1,688.9% | 4 qtrs — |
| 61 | SIMPLEX TRADING, LLC | 18.6K -34.5K (-64.9%) | 89.9K -16.1K (-15.2%) | 0.06% -0.104 pp | 0.00% +0.000 pp | USD1.93 +150.3% | 12 qtrs — |
| 62 | VIRTU FINANCIAL LLC | 17.6K +17.6K (+100.0%) | 85.0K +85.0K (+100.0%) | 0.05% +0.053 pp | 0.00% +0.003 pp | USD4.83 +0.0% | 1 qtrs NEW |
| 63 | LIGHTHOUSE INVESTMENT PARTNERS, LLC | 16.0K +16.0K (+100.0%) | 77.1K +77.1K (+100.0%) | 0.05% +0.048 pp | 0.00% +0.002 pp | USD4.83 +0.0% | 1 qtrs NEW |
| 64 | TORTOISE INVESTMENT MANAGEMENT, LLC | 13.9K +— (+0.0%) | 67.2K +39.2K (+140.3%) | 0.04% +0.000 pp | 0.01% +0.003 pp | USD2.65 +82.3% | 25 qtrs — |
| 65 | SCHONFELD STRATEGIC ADVISORS LLC | 13.2K +13.2K (+100.0%) | 63.8K +63.8K (+100.0%) | 0.04% +0.040 pp | 0.00% +0.000 pp | USD4.83 +0.0% | 1 qtrs NEW |
| 66 | CITADEL ADVISORS LLC | 11.7K +11.7K (+100.0%) | 56.5K +56.5K (+100.0%) | 0.04% +0.035 pp | 0.00% +0.000 pp | USD4.83 +0.0% | 1 qtrs NEW |
| 67 | PENSIONMARK FINANCIAL GROUP, LLC | 10.4K -200.0 (-1.9%) | 50.4K +29.1K (+135.8%) | 0.03% -0.001 pp | 0.00% +0.000 pp | USD1.19 +305.9% | 8 qtrs — |
| 68 | BEDEL FINANCIAL CONSULTING, INC. | 10.0K +— (+0.0%) | 48.3K +28.2K (+140.3%) | 0.03% +0.000 pp | 0.01% +0.003 pp | USD0.62 +679.0% | 11 qtrs — |
| 69 | LIDO ADVISORS, LLC | 13.9K +— (+0.0%) | 27.9K +— (+0.0%) | 0.04% +0.000 pp | 0.00% +0.000 pp | USD0.27 +1,688.9% | 4 qtrs — |
| 70 | BNP PARIBAS ARBITRAGE, SNC | 3.0K +2.9K (+3,168.8%) | 14.7K +14.5K (+7,751.9%) | 0.01% +0.009 pp | 0.00% +0.000 pp | USD4.70 +2.8% | 5 qtrs — |
| 71 | ROYAL BANK OF CANADA | 2.0K +2.0K (+100.0%) | 10.0K +10.0K (+100.0%) | 0.01% +0.006 pp | 0.00% +0.000 pp | USD4.83 +0.0% | 1 qtrs NEW |
| 72 | ALLWORTH FINANCIAL LP | 2.0K +2.0K (+100.0%) | 9.7K +9.7K (+100.0%) | 0.01% +0.006 pp | 0.00% +0.000 pp | USD4.83 +0.0% | 1 qtrs NEW |
| 73 | AMERICAN CAPITAL ADVISORY, LLC | 2.0K +— (+0.0%) | 9.4K +5.5K (+140.3%) | 0.01% +0.000 pp | 0.00% +0.002 pp | USD0.61 +691.8% | 9 qtrs — |
| 74 | FARTHER FINANCE ADVISORS, LLC | 684.00 -154.0 (-18.4%) | 3.3K +1.6K (+96.2%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD2.01 +140.3% | 2 qtrs — |
| 75 | SBI SECURITIES CO., LTD. | 57.00 -45.0 (-44.1%) | 275.00 +70.0 (+34.1%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD0.51 +847.1% | 5 qtrs — |
| 76 | ADVISOR GROUP HOLDINGS, INC. | 5.00 +— (+0.0%) | 24.00 +15.0 (+166.7%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD5.00 -3.4% | 24 qtrs — |
| 77 | FRONT ROW ADVISORS LLC | 2.00 +— (+0.0%) | 10.00 +6.0 (+150.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD— | 10 qtrs — |
| 78 | TOWER RESEARCH CAPITAL LLC (TRC) | — -1.6K (-100.0%) | — -3.2K (-100.0%) | 0.00% -0.005 pp | 0.00% 0.000 pp | USD— | 25 qtrs SOLD |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 57 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | AdvisorShares Psychedelics ETF PSIL | 6.34% | 2.81M | 1.84% |
| 2 | State Street SPDR S&P Pharmaceuticals ETF XPH | 0.94% | 4.45M | 0.35% |
| 3 | Virtus Biotech Clinical Trials ETF BBC | 0.59% | 341.5K | 0.65% |
| 4 | Xtrackers LPX Private Equity Swap UCITS ETF 1C XLPE.L | 0.52% | 1.63M | 0.70% |
| 5 | ALPS Medical Breakthroughs ETF SBIO | 0.34% | 734.2K | 0.50% |
| 6 | Direxion Daily Pharmaceutical & Medical Bull 3X ETF PILL | 0.20% | 45.8K | 1.22% |
| 7 | iShares Micro-Cap ETF IWC | 0.14% | 2.04M | 0.60% |
| 8 | Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF GSSC | 0.04% | 418.0K | 0.20% |
| 9 | iShares Russell 2000 Growth ETF IWO | 0.04% | 5.56M | 0.24% |
| 10 | Xtrackers Russell 2000 UCITS ETF 1C XRSU.L | 0.02% | 599.2K | 0.30% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
13
Sells
0
Shares acquired
5.21M
Shares disposed
—
Cash buys
6.00
Cash sales
—
Net activity
+5,211,665
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-15 | TRAVERSA SERGIO | Director / Officer | P-Purchase | A | Common Stock | 27,500 | 4.12 | 113.3K | 1,300,000 | D | ↗ |
| 2025-12-15 | Shenouda Maged | Officer | P-Purchase | A | Common Stock | 11,665 | 4.12 | 48.1K | 800,000 | D | ↗ |
| 2025-12-12 | TRAVERSA SERGIO | Director / Officer | A-Award | A | Stock Appreciation Rights | 1,198,000 | 4.06 | 4.86M | 1,198,000 | D | ↗ |
| 2025-12-12 | Shenouda Maged | Officer | A-Award | A | Stock Appreciation Rights | 828,000 | 4.06 | 3.36M | 828,000 | D | ↗ |
| 2025-12-12 | Kelly Paul Edward | Director / Officer | A-Award | A | Stock Appreciation Rights | 828,000 | 4.06 | 3.36M | 828,000 | D | ↗ |
| 2025-12-12 | GLASSPOOL JOHN | Director | A-Award | A | Stock Appreciation Rights | 164,000 | 4.06 | 665.8K | 164,000 | D | ↗ |
| 2025-12-12 | Fedeli Fabiana | Director | A-Award | A | Stock Appreciation Rights | 164,000 | 4.06 | 665.8K | 164,000 | D | ↗ |
| 2025-12-12 | Ence Chuck | Officer | A-Award | A | Stock Appreciation Rights | 828,000 | 4.06 | 3.36M | 828,000 | D | ↗ |
| 2025-12-12 | CASAMENTO CHARLES J | Director | A-Award | A | Stock Appreciation Rights | 164,000 | 4.06 | 665.8K | 164,000 | D | ↗ |
| 2025-11-05 | TRAVERSA SERGIO | Director / Officer | P-Purchase | A | Common Stock | 272,500 | 2.20 | 599.5K | 1,272,500 | D | ↗ |
| 2025-11-05 | Shenouda Maged | Officer | P-Purchase | A | Common Stock | 500,000 | 2.20 | 1.10M | 788,335 | D | ↗ |
| 2025-11-05 | Kelly Paul Edward | Director / Officer | P-Purchase | A | Common Stock | 90,000 | 2.20 | 198.0K | 502,295 | D | ↗ |
| 2025-11-05 | Ence Chuck | Officer | P-Purchase | A | Common Stock | 136,000 | 2.20 | 299.2K | 403,931 | D | ↗ |
| 2025-08-28 | TRAVERSA SERGIO | Director / Officer | P-Purchase | A | Common Stock | 55,976 | 0.74 | 41.4K | 1,000,000 | D | ↗ |
| 2025-08-27 | TRAVERSA SERGIO | Director / Officer | P-Purchase | A | Common Stock | 129,455 | 0.67 | 86.7K | 944,024 | D | ↗ |
| 2025-08-26 | TRAVERSA SERGIO | Director / Officer | P-Purchase | A | Common Stock | 80,545 | 0.62 | 49.9K | 814,569 | D | ↗ |
| 2025-06-26 | TRAVERSA SERGIO | Director / Officer | A-Award | A | Stock Option (right to buy) | 800,000 | 0.67 | 536.0K | 800,000 | D | ↗ |
| 2025-06-26 | Shenouda Maged | Officer | A-Award | A | Stock Option (right to buy) | 600,000 | 0.67 | 402.0K | 600,000 | D | ↗ |
| 2025-06-26 | Kelly Paul Edward | Director / Officer | A-Award | A | Stock Option (right to buy) | 400,000 | 0.67 | 268.0K | 400,000 | D | ↗ |
| 2025-06-26 | GLASSPOOL JOHN | Director | A-Award | A | Stock Option (right to buy) | 100,000 | 0.67 | 67.0K | 100,000 | D | ↗ |
| 2025-06-26 | Fedeli Fabiana | Director | A-Award | A | Stock Option (right to buy) | 100,000 | 0.67 | 67.0K | 100,000 | D | ↗ |
| 2025-06-26 | Ence Chuck | Officer | A-Award | A | Stock Option (right to buy) | 400,000 | 0.67 | 268.0K | 400,000 | D | ↗ |
| 2025-06-26 | CASAMENTO CHARLES J | Director | A-Award | A | Stock Option (right to buy) | 100,000 | 0.67 | 67.0K | 100,000 | D | ↗ |
| 2025-05-20 | TRAVERSA SERGIO | Director / Officer | P-Purchase | A | Common Stock | 147,686 | 0.56 | 82.2K | 734,024 | D | ↗ |
| 2025-05-20 | Shenouda Maged | Officer | P-Purchase | A | Common Stock | 60,000 | 0.52 | 31.4K | 288,335 | D | ↗ |
| 2025-05-19 | TRAVERSA SERGIO | Director / Officer | P-Purchase | A | Common Stock | 30,000 | 0.50 | 15.0K | 586,338 | D | ↗ |
| 2025-05-19 | Shenouda Maged | Officer | P-Purchase | A | Common Stock | 90,000 | 0.49 | 43.7K | 228,335 | D | ↗ |
| 2025-05-16 | TRAVERSA SERGIO | Director / Officer | P-Purchase | A | Common Stock | 172,314 | 0.45 | 77.5K | 556,338 | D | ↗ |
| 2025-05-16 | Shenouda Maged | Officer | P-Purchase | A | Common Stock | 50,000 | 0.44 | 22.1K | 138,335 | D | ↗ |
| 2025-05-16 | Kelly Paul Edward | Director / Officer | P-Purchase | A | Common Stock | 200,000 | 0.43 | 86.1K | 412,295 | D | ↗ |
| 2025-05-16 | Ence Chuck | Officer | P-Purchase | A | Common Stock | 228,961 | 0.45 | 103.3K | 267,931 | D | ↗ |
| 2024-10-22 | CASAMENTO CHARLES J | Director | G-Gift | D | Common Stock | 13,000 | 0.00 | — | 0 | D | ↗ |
| 2024-09-11 | TRAVERSA SERGIO | Director / Officer | P-Purchase | A | Common Stock | 51,407 | 2.99 | 153.7K | 384,024 | — | ↗ |
| 2024-09-11 | Shenouda Maged | Officer | P-Purchase | A | Common Stock | 24,120 | 2.95 | 71.2K | 88,335 | — | ↗ |
| 2024-09-10 | TRAVERSA SERGIO | Director / Officer | P-Purchase | A | Common Stock | 33,014 | 2.75 | 90.8K | 332,617 | — | ↗ |
| 2024-09-10 | Shenouda Maged | Officer | P-Purchase | A | Common Stock | 21,118 | 2.73 | 57.7K | 64,215 | — | ↗ |
| 2024-09-09 | TRAVERSA SERGIO | Director / Officer | P-Purchase | A | Common Stock | 55,579 | 2.71 | 150.6K | 299,603 | — | ↗ |
| 2024-09-09 | Shenouda Maged | Officer | P-Purchase | A | Common Stock | 8,194 | 2.55 | 20.9K | 43,097 | — | ↗ |
| 2024-09-09 | Kelly Paul Edward | Director | P-Purchase | A | Common Stock | 25,000 | 2.59 | 64.8K | 212,295 | — | ↗ |
| 2024-09-09 | CASAMENTO CHARLES J | Director | P-Purchase | A | Common Stock | 13,000 | 2.56 | 33.3K | 13,000 | — | ↗ |
| 2024-05-24 | TRAVERSA SERGIO | Director / Officer | J-Other | D | Stock Option (right to buy) | 122,358 | 2.48 | 303.4K | 183,881 | — | ↗ |
| 2024-05-24 | Shenouda Maged | Officer | J-Other | D | Stock Option (right to buy) | 54,624 | 2.48 | 135.5K | 82,090 | — | ↗ |
| 2024-05-24 | Kelly Paul Edward | Director | J-Other | D | Stock Option (right to buy) | 43,700 | 2.48 | 108.4K | 65,672 | — | ↗ |
| 2024-05-24 | GLASSPOOL JOHN | Director | J-Other | D | Stock Option (right to buy) | 20,976 | 2.48 | 52.0K | 31,522 | — | ↗ |
| 2024-05-24 | Fedeli Fabiana | Director | J-Other | D | Stock Option (right to buy) | 20,976 | 2.48 | 52.0K | 31,522 | — | ↗ |
| 2024-05-24 | Ence Chuck | Officer | J-Other | D | Stock Option (right to buy) | 54,624 | 2.48 | 135.5K | 82,090 | — | ↗ |
| 2024-05-24 | CASAMENTO CHARLES J | Director | J-Other | D | Stock Option (right to buy) | 20,976 | 2.48 | 52.0K | 31,522 | — | ↗ |
| 2024-01-31 | TRAVERSA SERGIO | Director / Officer | P-Purchase | A | Common Stock | 27,460 | 4.00 | 109.8K | 244,024 | — | ↗ |
| 2024-01-31 | Shenouda Maged | Officer | P-Purchase | A | Common Stock | 6,875 | 4.06 | 27.9K | 34,903 | — | ↗ |
| 2024-01-31 | Ence Chuck | Officer | P-Purchase | A | Common Stock | 13,670 | 4.05 | 55.4K | 38,970 | — | ↗ |
| 2024-01-30 | TRAVERSA SERGIO | Director / Officer | P-Purchase | A | Common Stock | 40,999 | 3.90 | 159.9K | 216,564 | — | ↗ |
| 2024-01-30 | Shenouda Maged | Officer | P-Purchase | A | Common Stock | 15,000 | 3.89 | 58.3K | 28,028 | — | ↗ |
| 2024-01-30 | Ence Chuck | Officer | P-Purchase | A | Common Stock | 14,500 | 3.87 | 56.1K | 25,300 | — | ↗ |
| 2024-01-29 | TRAVERSA SERGIO | Director / Officer | P-Purchase | A | Common Stock | 31,541 | 3.71 | 117.0K | 175,565 | — | ↗ |
| 2024-01-29 | Shenouda Maged | Officer | P-Purchase | A | Common Stock | 10,800 | 3.65 | 39.5K | 13,028 | — | ↗ |
| 2024-01-29 | Ence Chuck | Officer | P-Purchase | A | Common Stock | 10,800 | 3.65 | 39.4K | 10,800 | — | ↗ |
| 2023-12-15 | TRAVERSA SERGIO | Director / Officer | A-Award | A | Stock Option (right to buy) | 183,881 | 2.48 | 456.0K | 183,881 | — | ↗ |
| 2023-12-15 | Shenouda Maged | Officer | A-Award | A | Stock Option (right to buy) | 82,090 | 2.48 | 203.6K | 82,090 | — | ↗ |
| 2023-12-15 | Kelly Paul Edward | Director | A-Award | A | Stock Option (right to buy) | 65,672 | 2.48 | 162.9K | 65,672 | — | ↗ |
| 2023-12-15 | GLASSPOOL JOHN | Director | A-Award | A | Stock Option (right to buy) | 31,522 | 2.48 | 78.2K | 31,522 | — | ↗ |
| 2023-12-15 | Fedeli Fabiana | Director | A-Award | A | Stock Option (right to buy) | 31,522 | 2.48 | 78.2K | 31,522 | — | ↗ |
| 2023-12-15 | Ence Chuck | Officer | A-Award | A | Stock Option (right to buy) | 82,090 | 2.48 | 203.6K | 82,090 | — | ↗ |
| 2023-12-15 | CASAMENTO CHARLES J | Director | A-Award | A | Stock Option (right to buy) | 31,522 | 2.48 | 78.2K | 31,522 | — | ↗ |
| 2023-05-25 | TRAVERSA SERGIO | Director / Officer | A-Award | A | Stock Option (right to buy) | 527,211 | 3.37 | 1.78M | 850,728 | — | ↗ |
| 2023-05-25 | Shenouda Maged | Officer | A-Award | A | Stock Option (right to buy) | 317,643 | 3.37 | 1.07M | 512,560 | — | ↗ |
| 2023-05-25 | SCHMIDT ERIC THOMAS | Director | A-Award | A | Stock Option (right to buy) | 92,958 | 3.37 | 313.3K | 150,000 | — | ↗ |
| 2023-05-25 | Kelly Paul Edward | Director | A-Award | A | Stock Option (right to buy) | 92,958 | 3.37 | 313.3K | 150,000 | — | ↗ |
| 2023-05-25 | GLASSPOOL JOHN | Director | A-Award | A | Stock Option (right to buy) | 92,958 | 3.37 | 313.3K | 150,000 | — | ↗ |
| 2023-05-25 | Fedeli Fabiana | Director | A-Award | A | Stock Option (right to buy) | 200,000 | 4.22 | 844.0K | 200,000 | — | ↗ |
| 2023-05-25 | Ence Chuck | Officer | A-Award | A | Stock Option (right to buy) | 321,238 | 3.37 | 1.08M | 518,361 | — | ↗ |
| 2023-05-25 | CASAMENTO CHARLES J | Director | A-Award | A | Stock Option (right to buy) | 92,958 | 3.37 | 313.3K | 150,000 | — | ↗ |
| 2023-05-23 | O'Gorman Cedric | Officer | P-Purchase | A | Common Stock | 10,000 | 3.18 | 31.8K | 10,121 | — | ↗ |
| 2023-01-12 | Fedeli Fabiana | — | — | — | — | — | — | — | 0 | — | ↗ |
| 2023-01-06 | O'Gorman Cedric | Officer | — | D | Common Stock | 0 | 0.00 | — | 121 | — | ↗ |
| 2022-12-31 | CASAMENTO CHARLES J | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-12-16 | TRAVERSA SERGIO | Officer | A-Award | A | Stock Option (right to buy) | 323,517 | 0.00 | — | 323,517 | — | ↗ |
| 2022-12-16 | Shenouda Maged | Officer | A-Award | A | Stock Option (right to buy) | 194,917 | 0.00 | — | 194,917 | — | ↗ |
| 2022-12-16 | SCHMIDT ERIC THOMAS | Director | A-Award | A | Stock Option (right to buy) | 57,042 | 0.00 | — | 57,042 | — | ↗ |
| 2022-12-16 | Kelly Paul Edward | Director | A-Award | A | Stock Option (right to buy) | 57,042 | 0.00 | — | 57,042 | — | ↗ |
| 2022-12-16 | GLASSPOOL JOHN | Director | A-Award | A | Stock Option (right to buy) | 57,042 | 0.00 | — | 57,042 | — | ↗ |
| 2022-12-16 | Ence Chuck | Officer | A-Award | A | Stock Option (right to buy) | 197,123 | 0.00 | — | 197,123 | — | ↗ |
| 2022-12-16 | CASAMENTO CHARLES J | Director | A-Award | A | Stock Option (right to buy) | 57,042 | 0.00 | — | 57,042 | — | ↗ |
| 2022-12-08 | TRAVERSA SERGIO | Officer | P-Purchase | A | Common Stock | 55,250 | 2.10 | 115.8K | 144,024 | — | ↗ |
| 2022-07-01 | TRAVERSA SERGIO | Director / Officer | M-Exempt | D | Stock Option (right to buy) | 13,755 | 16.00 | 220.1K | 0 | — | ↗ |
| 2022-06-30 | TRAVERSA SERGIO | Officer | S-Sale | D | Common Stock | 4,068 | 18.32 | 74.5K | 88,774 | — | ↗ |
| 2022-05-25 | TRAVERSA SERGIO | Director / Officer | A-Award | A | Stock Option (right to buy) | 651,821 | 19.03 | 12.40M | 1,143,994 | — | ↗ |
| 2022-05-25 | Shenouda Maged | Officer | A-Award | A | Stock Option (right to buy) | 295,211 | 19.03 | 5.62M | 522,729 | — | ↗ |
| 2022-05-25 | SCHMIDT ERIC THOMAS | Director | A-Award | A | Stock Option (right to buy) | 91,235 | 19.03 | 1.74M | 150,000 | — | ↗ |
| 2022-05-25 | Kelly Paul Edward | Director | A-Award | A | Stock Option (right to buy) | 182,470 | 19.03 | 3.47M | 300,000 | — | ↗ |
| 2022-05-25 | GLASSPOOL JOHN | Director | A-Award | A | Stock Option (right to buy) | 91,235 | 19.03 | 1.74M | 150,000 | — | ↗ |
| 2022-05-25 | Ence Chuck | Officer | A-Award | A | Stock Option (right to buy) | 295,404 | 19.03 | 5.62M | 522,236 | — | ↗ |
| 2022-05-25 | CASAMENTO CHARLES J | Director | A-Award | A | Stock Option (right to buy) | 91,235 | 19.03 | 1.74M | 150,000 | — | ↗ |
| 2022-04-04 | Kelly Paul Edward | Director | S-Sale | D | Common Stock | 10,000 | 30.04 | 300.4K | 187,295 | — | ↗ |
| 2022-04-01 | CASAMENTO CHARLES J | Director | M-Exempt | A | Stock Option (right to buy) | 19,800 | 0.00 | — | 77,511 | — | ↗ |
| 2022-01-03 | Kelly Paul Edward | Director | M-Exempt | D | Common Stock | 20,000 | 3.24 | 64.8K | 187,295 | — | ↗ |
| 2021-12-17 | TRAVERSA SERGIO | Director / Officer | A-Award | A | Stock Option (right to buy) | 492,173 | 19.03 | 9.37M | 492,173 | — | ↗ |
| 2021-12-17 | Shenouda Maged | Officer | A-Award | A | Stock Option (right to buy) | 227,518 | 19.03 | 4.33M | 227,518 | — | ↗ |
| 2021-12-17 | SCHMIDT ERIC THOMAS | Director | A-Award | A | Stock Option (right to buy) | 58,765 | 19.03 | 1.12M | 58,765 | — | ↗ |
| 2021-12-17 | Kelly Paul Edward | Director | A-Award | A | Stock Option (right to buy) | 117,530 | 19.03 | 2.24M | 117,530 | — | ↗ |
| 2021-12-17 | GLASSPOOL JOHN | Director | A-Award | A | Stock Option (right to buy) | 58,765 | 19.03 | 1.12M | 58,765 | — | ↗ |
| 2021-12-17 | Ence Chuck | Officer | A-Award | A | Stock Option (right to buy) | 226,832 | 19.03 | 4.32M | 226,832 | — | ↗ |
| 2021-12-17 | CASAMENTO CHARLES J | Director | A-Award | A | Stock Option (right to buy) | 58,765 | 19.03 | 1.12M | 58,765 | — | ↗ |
| 2021-09-22 | CASAMENTO CHARLES J | Director | M-Exempt | D | Options to purchase common stock | 1,900 | 3.24 | 6.2K | 97,311 | — | ↗ |
| 2021-08-17 | CASAMENTO CHARLES J | Director | M-Exempt | D | Options to purchase common stock | 10,000 | 4.60 | 46.0K | 102,500 | — | ↗ |
| 2021-07-15 | CASAMENTO CHARLES J | Director | S-Sale | D | Common Stock | 1,164 | 32.49 | 37.8K | 4,700 | — | ↗ |
| 2021-07-08 | TRAVERSA SERGIO | Director / Officer | G-Gift | D | Stock Option (right to buy) | 31,250 | 33.43 | 1.04M | 225,000 | D | ↗ |
| 2021-07-08 | Kelly Paul Edward | Director | G-Gift | D | Stock Option (right to buy) | 56,000 | 43.47 | 2.43M | 94,000 | — | ↗ |
| 2021-06-01 | CASAMENTO CHARLES J | Director | S-Sale | D | Common Stock | 520 | 34.08 | 17.7K | 9,430 | — | ↗ |
| 2021-05-03 | CASAMENTO CHARLES J | Director | S-Sale | D | Common Stock | 3,000 | 38.22 | 114.6K | 9,950 | — | ↗ |
| 2021-04-01 | CASAMENTO CHARLES J | Director | S-Sale | D | Common Stock | 1,309 | 35.93 | 47.0K | 14,641 | — | ↗ |
| 2021-03-10 | TRAVERSA SERGIO | Director / Officer | S-Sale | D | Common Stock | 2,983 | 35.09 | 104.7K | 88,774 | — | ↗ |
| 2021-03-10 | Shenouda Maged | Officer | S-Sale | D | Common Stock | 2,373 | 35.11 | 83.3K | 2,228 | — | ↗ |
| 2021-03-09 | TRAVERSA SERGIO | Director / Officer | M-Exempt | A | Common Stock | 10,000 | 3.24 | 32.4K | 98,774 | — | ↗ |
| 2021-03-09 | Shenouda Maged | Officer | S-Sale | D | Common Stock | 1,800 | 36.02 | 64.8K | 4,601 | — | ↗ |
| 2021-03-09 | Kelly Paul Edward | Director | M-Exempt | A | Common Stock | 5,000 | 3.24 | 16.2K | 172,295 | — | ↗ |
| 2021-03-08 | Shenouda Maged | Officer | S-Sale | D | Common Stock | 100 | 35.00 | 3.5K | 12,128 | — | ↗ |
| 2021-03-01 | CASAMENTO CHARLES J | Director | S-Sale | D | Common Stock | 3,000 | 33.87 | 101.6K | 15,950 | — | ↗ |
| 2021-02-24 | TRAVERSA SERGIO | Director / Officer | M-Exempt | D | Options to purchase common stock | 10,000 | 3.24 | 32.4K | 109,211 | — | ↗ |
| 2021-02-24 | Shenouda Maged | Officer | S-Sale | D | Common Stock | 1,400 | 34.67 | 48.5K | 2,228 | — | ↗ |
| 2021-02-24 | Kelly Paul Edward | Director | S-Sale | D | Common Stock | 2,429 | 33.67 | 81.8K | 169,866 | — | ↗ |
| 2021-02-16 | Kelly Paul Edward | Director | M-Exempt | A | Common Stock | 5,000 | 6.00 | 30.0K | 167,295 | — | ↗ |
| 2021-02-11 | TRAVERSA SERGIO | Director / Officer | S-Sale | D | Common Stock | 1,446 | 35.43 | 51.2K | 88,774 | — | ↗ |
| 2021-02-11 | Shenouda Maged | Officer | S-Sale | D | Common Stock | 1,428 | 35.39 | 50.5K | 2,228 | — | ↗ |
| 2021-02-10 | TRAVERSA SERGIO | Director / Officer | S-Sale | D | Common Stock | 1,930 | 35.28 | 68.1K | 88,774 | — | ↗ |
| 2021-02-10 | Shenouda Maged | Officer | S-Sale | D | Common Stock | 2,410 | 35.20 | 84.8K | 2,228 | — | ↗ |
| 2021-02-09 | TRAVERSA SERGIO | Director / Officer | S-Sale | D | Common Stock | 5,963 | 35.21 | 209.9K | 90,704 | — | ↗ |
| 2021-02-09 | Shenouda Maged | Officer | S-Sale | D | Common Stock | 5,359 | 35.24 | 188.8K | 4,638 | — | ↗ |
| 2021-02-09 | Kelly Paul Edward | Director | S-Sale | D | Common Stock | 2,069 | 35.29 | 73.0K | 162,295 | — | ↗ |
| 2021-02-08 | TRAVERSA SERGIO | Director / Officer | M-Exempt | D | Options to purchase common stock | 11,206 | 3.24 | 36.3K | 120,657 | — | ↗ |
| 2021-02-08 | Shenouda Maged | Officer | M-Exempt | A | Common Stock | 11,372 | 3.24 | 36.8K | 13,600 | — | ↗ |
| 2021-02-08 | Kelly Paul Edward | Director | M-Exempt | D | Options to purchase common stock | 5,000 | 3.24 | 16.2K | 55,500 | — | ↗ |
| 2021-02-03 | TRAVERSA SERGIO | Director / Officer | S-Sale | D | Common Stock | 100 | 35.00 | 3.5K | 88,874 | — | ↗ |
| 2021-02-03 | Shenouda Maged | Officer | S-Sale | D | Common Stock | 100 | 35.00 | 3.5K | 2,228 | — | ↗ |
| 2021-02-02 | TRAVERSA SERGIO | Director / Officer | S-Sale | D | Common Stock | 3,178 | 35.08 | 111.5K | 88,874 | — | ↗ |
| 2021-02-02 | Shenouda Maged | Officer | M-Exempt | D | Options to purchase common stock | 3,200 | 3.24 | 10.4K | 96,050 | — | ↗ |
| 2021-02-02 | Kelly Paul Edward | Director | S-Sale | D | Common Stock | 2,315 | 35.04 | 81.1K | 162,295 | — | ↗ |
| 2021-02-01 | Kelly Paul Edward | Director | M-Exempt | D | Options to purchase common stock | 15,000 | 3.24 | 48.6K | 66,415 | — | ↗ |
| 2021-02-01 | CASAMENTO CHARLES J | Director | S-Sale | D | Common Stock | 1,663 | 33.90 | 56.4K | 18,950 | — | ↗ |
| 2021-01-27 | TRAVERSA SERGIO | Director / Officer | S-Sale | D | Common Stock | 4,351 | 31.77 | 138.2K | 81,142 | — | ↗ |
| 2021-01-27 | Shenouda Maged | Officer | M-Exempt | A | Common Stock | 3,000 | 3.24 | 9.7K | 5,228 | — | ↗ |
| 2021-01-27 | Kelly Paul Edward | Director | S-Sale | D | Common Stock | 168 | 33.40 | 5.6K | 147,295 | — | ↗ |
| 2021-01-26 | TRAVERSA SERGIO | Director / Officer | S-Sale | D | Common Stock | 600 | 35.15 | 21.1K | 75,493 | — | ↗ |
| 2021-01-26 | Shenouda Maged | Officer | S-Sale | D | Common Stock | 607 | 35.16 | 21.3K | 2,228 | — | ↗ |
| 2021-01-26 | Kelly Paul Edward | Director | S-Sale | D | Common Stock | 685 | 35.16 | 24.1K | 147,295 | — | ↗ |
| 2021-01-25 | TRAVERSA SERGIO | Director / Officer | S-Sale | D | Common Stock | 1,300 | 35.29 | 45.9K | 76,093 | — | ↗ |
| 2021-01-25 | Shenouda Maged | Officer | S-Sale | D | Common Stock | 1,280 | 35.27 | 45.1K | 2,835 | — | ↗ |
| 2021-01-25 | Kelly Paul Edward | Director | S-Sale | D | Common Stock | 1,300 | 35.27 | 45.9K | 147,980 | — | ↗ |
| 2021-01-22 | TRAVERSA SERGIO | Director / Officer | S-Sale | D | Common Stock | 434 | 36.15 | 15.7K | 77,393 | — | ↗ |
| 2021-01-22 | Shenouda Maged | Officer | S-Sale | D | Common Stock | 409 | 36.15 | 14.8K | 4,115 | — | ↗ |
| 2021-01-22 | Kelly Paul Edward | Director | M-Exempt | D | Options to purchase common stock | 4,085 | 3.24 | 13.2K | 86,415 | — | ↗ |
| 2021-01-07 | TRAVERSA SERGIO | Director / Officer | A-Award | A | Options to purchase common stock | 250,000 | 33.43 | 8.36M | 250,000 | — | ↗ |
| 2021-01-07 | Shenouda Maged | Officer | A-Award | A | Options to purchase common stock | 127,500 | 33.43 | 4.26M | 127,500 | — | ↗ |
| 2021-01-07 | SCHMIDT ERIC THOMAS | Director | A-Award | A | Options to purchase common stock | 100,000 | 33.43 | 3.34M | 100,000 | — | ↗ |
| 2021-01-07 | Kelly Paul Edward | Director | A-Award | A | Options to purchase common stock | 150,000 | 33.43 | 5.01M | 150,000 | — | ↗ |
| 2021-01-07 | GLASSPOOL JOHN | Director | A-Award | A | Options to purchase common stock | 100,000 | 33.43 | 3.34M | 100,000 | — | ↗ |
| 2021-01-07 | Ence Chuck | Officer | A-Award | A | Options to purchase common stock | 112,500 | 33.43 | 3.76M | 112,500 | — | ↗ |
| 2021-01-07 | CASAMENTO CHARLES J | Director | A-Award | A | Options to purchase common stock | 100,000 | 33.43 | 3.34M | 100,000 | — | ↗ |
| 2021-01-04 | CASAMENTO CHARLES J | Director | S-Sale | D | Common Stock | 3,000 | 32.11 | 96.3K | 21,950 | — | ↗ |
| 2020-12-01 | CASAMENTO CHARLES J | Director | S-Sale | D | Common Stock | 3,000 | 35.74 | 107.2K | 24,950 | — | ↗ |
| 2020-11-24 | CASAMENTO CHARLES J | Director | G-Gift | D | Common Stock | 21,223 | 0.00 | — | 27,950 | — | ↗ |
| 2020-11-02 | CASAMENTO CHARLES J | Director | S-Sale | D | Common Stock | 3,000 | 30.29 | 90.9K | 49,173 | — | ↗ |
| 2020-10-01 | CASAMENTO CHARLES J | Director | S-Sale | D | Common Stock | 3,000 | 37.99 | 114.0K | 52,173 | — | ↗ |
| 2020-09-01 | CASAMENTO CHARLES J | Director | S-Sale | D | Common Stock | 3,000 | 34.74 | 104.2K | 55,173 | — | ↗ |
| 2020-08-18 | TRAVERSA SERGIO | Director / Officer | M-Exempt | D | Options to purchase common stock | 50,008 | 3.24 | 162.0K | 162,492 | — | ↗ |
| 2020-08-18 | Kelly Paul Edward | Director | M-Exempt | A | Common Stock | 22,000 | 3.24 | 71.3K | 149,121 | — | ↗ |
| 2020-08-18 | CASAMENTO CHARLES J | Director | M-Exempt | D | Options to purchase common stock | 26,362 | 3.24 | 85.4K | 33,404 | — | ↗ |
| 2020-08-03 | CASAMENTO CHARLES J | Director | S-Sale | D | Common Stock | 3,000 | 35.74 | 107.2K | 34,000 | — | ↗ |
| 2020-07-01 | CASAMENTO CHARLES J | Director | S-Sale | D | Common Stock | 3,000 | 43.89 | 131.7K | 37,000 | — | ↗ |
| 2020-04-09 | SCHMIDT ERIC THOMAS | Director | X-InTheMoney | A | Common Stock | 12,500 | 9.00 | 112.5K | 100,000 | — | ↗ |
| 2020-03-17 | CASAMENTO CHARLES J | Director | G-Gift | D | Common Stock | 21,484 | 0.00 | — | 40,000 | — | ↗ |
| 2020-03-09 | Wessel Thomas | Officer | — | D | Options to purchase common stock | 350,000 | 45.61 | 15.96M | 0 | — | ↗ |
| 2019-12-24 | CASAMENTO CHARLES J | Director | F-InKind | D | Common Stock | 2,388 | 40.64 | 97.0K | 61,484 | — | ↗ |
| 2019-12-19 | Vitolo Ottavio V. | Officer | A-Award | A | Options to purchase common stock | 105,000 | 43.47 | 4.56M | 105,000 | — | ↗ |
| 2019-12-19 | TRAVERSA SERGIO | Director / Officer | A-Award | A | Options to purchase common stock | 350,000 | 43.47 | 15.21M | 350,000 | — | ↗ |
| 2019-12-19 | Shenouda Maged | Director | A-Award | A | Options to purchase common stock | 120,000 | 43.47 | 5.22M | 120,000 | — | ↗ |
| 2019-12-19 | SCHMIDT ERIC THOMAS | Director | — | D | Options to purchase common stock | 200,000 | 43.47 | 8.69M | 0 | — | ↗ |
| 2019-12-19 | Kelly Paul Edward | Director | A-Award | A | Options to purchase common stock | 150,000 | 43.47 | 6.52M | 150,000 | — | ↗ |
| 2019-12-19 | GLASSPOOL JOHN | Director | — | D | Options to purchase common stock | 200,000 | 43.47 | 8.69M | 0 | — | ↗ |
| 2019-12-19 | Ence Chuck | Officer | A-Award | A | Options to purchase common stock | 60,000 | 43.47 | 2.61M | 60,000 | — | ↗ |
| 2019-12-19 | CASAMENTO CHARLES J | Director | A-Award | A | Options to purchase common stock | 100,000 | 43.47 | 4.35M | 100,000 | — | ↗ |
| 2019-10-21 | Shenouda Maged | Director | P-Purchase | A | Common Stock | 978 | 23.00 | 22.5K | 2,228 | — | ↗ |
| 2019-10-18 | Kelly Paul Edward | Director | P-Purchase | A | Common Stock | 100 | 19.04 | 1.9K | 123,221 | — | ↗ |
| 2019-07-29 | Vitolo Ottavio V. | Officer | A-Award | A | Options to purchase common stock | 150,000 | 2.20 | 330.0K | 150,000 | — | ↗ |
| 2019-07-29 | TRAVERSA SERGIO | Director / Officer | A-Award | A | Options to purchase common stock | 1,700,000 | 2.20 | 3.74M | 1,700,000 | — | ↗ |
| 2019-07-29 | Shenouda Maged | Director | A-Award | A | Options to purchase common stock | 500,000 | 2.20 | 1.10M | 500,000 | — | ↗ |
| 2019-07-29 | Kelly Paul Edward | Director | A-Award | A | Options to purchase common stock | 600,000 | 2.20 | 1.32M | 600,000 | — | ↗ |
| 2019-07-29 | Ence Chuck | Officer | — | D | Options to purchase common stock | 100,000 | 2.20 | 220.0K | 0 | — | ↗ |
| 2019-07-29 | CASAMENTO CHARLES J | Director | A-Award | A | Options to purchase common stock | 500,000 | 2.20 | 1.10M | 500,000 | — | ↗ |
| 2019-05-14 | SCHMIDT ERIC THOMAS | Director | — | D | Options to purchase common stock | 12,500 | 9.00 | 112.5K | 0 | — | ↗ |
| 2019-05-14 | Kelly Paul Edward | Director | P-Purchase | A | Common Stock | 100,000 | 1.50 | 150.0K | 488,483 | — | ↗ |
| 2018-12-20 | Vitolo Ottavio V. | Officer | A-Award | A | Options to purchase common stock | 400,000 | 1.15 | 460.0K | 400,000 | — | ↗ |
| 2018-12-20 | TRAVERSA SERGIO | Director / Officer | A-Award | A | Options to purchase common stock | 900,000 | 1.15 | 1.04M | 900,000 | — | ↗ |
| 2018-12-20 | Shenouda Maged | Director | A-Award | A | Options to purchase common stock | 450,000 | 1.15 | 517.5K | 450,000 | — | ↗ |
| 2018-12-20 | Kelly Paul Edward | Director | A-Award | A | Options to purchase common stock | 500,000 | 1.15 | 575.0K | 500,000 | — | ↗ |
| 2018-12-20 | CASAMENTO CHARLES J | Director | A-Award | A | Options to purchase common stock | 450,000 | 1.15 | 517.5K | 450,000 | — | ↗ |
| 2018-12-11 | Kelly Paul Edward | Director | P-Purchase | A | Common Stock | 5,000 | 1.21 | 6.1K | 388,483 | — | ↗ |
| 2018-12-03 | SCHMIDT ERIC THOMAS | Director | — | D | Options to purchase common stock | 32,500 | 6.00 | 195.0K | 0 | — | ↗ |
| 2018-10-18 | Kelly Paul Edward | Director | C-Conversion | A | Common Stock | 223,483 | 0.72 | 160.9K | 383,483 | — | ↗ |
| 2018-10-12 | Kelly Paul Edward | Director | P-Purchase | A | Common Stock | 150,000 | 0.90 | 135.0K | 160,000 | — | ↗ |
| 2018-04-02 | Vitolo Ottavio V. | Officer | — | D | Options to purchase common stock | 300,000 | 0.88 | 264.0K | 0 | — | ↗ |
Executive team
Top executives
Shares Outstanding
73.33M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Sergio Traversa | Chief Executive Officer & Director | 4M | — |
| Maged S. Shenouda | Chief Financial Officer | 3M | male |
| Charles S. Ence | Chief Accounting & Compliance Officer | 2M | male |
| Paul E. Kelly | Chief Operating Officer & Director | 2M | male |
| Andrew Cutler | Senior Clinical Development Advisor | — | — |
| Raj S. Pruthi | Chief Medical Officer of Urology | — | — |
| Richard Mangano | Consultant | — | — |
| Gina DiGuglielmo | Vice President & Head of Clinical Operations | — | female |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for RLMD
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
